Coronavirus: dermatology update
In response to the coronavirus (COVID-19) outbreak, please read our advice and information before attending the service.
We have five highly specialised laboratory services dedicated to the diagnosis and management of skin disease:
- dermatopathology - identifies pathology changes associated with skin diseases/abnormalities/infections by examination of the skin structure microscopically.
- immunofluorescence - provides immunological diagnoses of acquired blistering diseases using tissue biopsy and blood samples.
- mycology - identifies fungal infections of skin, hair, nails and mucous membranes by microscopy and culture.
- skin tumour unit - offers a molecular diagnostic service using PCR based techniques to identify clonal T cell and B cell populations to assist in the diagnosis of primary cutaneous T and B cell lymphomas.
- national epidermolysis bullosa (EB) laboratory - identifies skin blistering diseases using electron microscopy, immunohistochemistry and mutation analysis. There is also a prenatal diagnostic service for epidermolysis bullosa.
The laboratories work closely with dermatologists, and being an integral part of St John's Institute of Dermatology, uniquely form a centre of excellence where all services form part of a single team.
We are committed to the provision of accurate diagnostic and prognostic information relevant to treatment of skin disease, education of clinical colleagues and students, and advancement of research into their various subspecialties.